|
HS Code |
310631 |
As an accredited 3-Bromo-1H-Pyrazolo[4,3-C]Pyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 3-Bromo-1H-Pyrazolo[4,3-C]Pyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every now and then, a compound shows up that changes the way we approach chemistry in the lab. 3-Bromo-1H-Pyrazolo[4,3-C]Pyridine is one of those rare compounds researchers from diverse scientific backgrounds keep coming back to. Speaking from years in academic settings and some time spent exploring small molecule libraries, I can say this molecule consistently draws attention for good reasons. Its rigid pyrazolopyridine core acts as a solid starting point for transforming basic scaffolds into more complex, bioactive targets.
Anyone who’s spent time working with nitrogen-rich heterocycles knows they aren’t always the most cooperative partners on the bench. Some are finicky about moisture, others sensitive to light. The 3-bromo substitution at the pyrazolopyridine framework introduces an option that is robust, reliable, and well-characterized. From its off-white crystalline appearance to its predictable melting point, it hardly ever disappoints during storage or reaction setup. Experienced chemists appreciate high-purity batches, and producers deliver this compound with strict spectroscopic confirmation, almost always above the 98% purity mark. Every time I’ve tested a new lot by NMR or LC-MS, batch consistency sticks out.
Some chemicals just fill a gap, but this one goes beyond by opening doors across different segments of research. Want to build a library of kinase inhibitors? You’ll find this structure a handy starting block thanks to its compatibility with modern coupling techniques. Working on an agrochemical lead? The pattern holds because the bromo substituent grants easy access to versatile C-C or C-N bonds through Suzuki or Buchwald-Hartwig methods. It’s compatible with many palladium-catalyzed reactions—a staple in any advanced organic chemistry toolbox.
As a teaching assistant years ago, helping students design reactions, I saw firsthand how using robust reagents can shape a practical education. Not every compound helps students see rapid, clean transformations. Seeing this molecule used in upper-level labs, it’s clear why researchers and students both benefit: it enables proof-of-concept runs without unpredictable hiccups.
Over the last decade, pharmaceutical researchers have given pyrazolopyridine derivatives a long, hard look, especially for kinase-related targets. There are plenty of analogs out there: some with chloro or iodo groups, others with methyl substitutions. The bromine atom in the 3-position achieves a key balance between reactivity and selectivity. With chlorinated analogs, the reactivity in cross-couplings can lag. With iodine, you often get too much reactivity and a higher price tag. Bromine carries just enough heft to invite coupling yet resists decomposition. In my hands, bromo variants show more predictable behavior during C-H functionalization and give better yields in cross-coupling compared to their chloro cousins.
It’s not just about reactivity. Handling differences count, too. Bromo compounds like this typically have less off-target reactivity—that helps when you need reproducibly clean transformations, avoiding unwanted byproducts. Many times, I’ve run parallel reactions with chloro, bromo, and iodo variants, and the pyrazolopyridine scaffold with bromine keeps showing a sweet spot between cost, stability, and performance.
Go beyond journals—look into patent filings, and you’ll see this backbone everywhere: anticancer compounds, anti-inflammatory candidates, enzyme modulators, and even agricultural protectants. More medicinal chemistry groups report breakthroughs with pyrazolopyridine derivatives than ever before. Part of that comes from the flexibility this scaffold offers. With a bromine at the 3-position, you unlock late-stage diversification without needing to re-optimize every part of the synthesis. This saves enormous time and cost.
From small biotechs to large pharmaceutical teams, this compound is valued not just for what it can become, but for how easily it adopts new molecular decorations. One biopharma group I interacted with in the past pushed their pipeline forward by starting with this very scaffold, ultimately landing a clinical candidate. They cited the clean reactivity profile and ease in scaling up preparative runs—so it isn’t just academic appeal.
Laboratory safety and sustainability get more attention every year, and rightly so. I remember working in an early-stage start-up without advanced containment facilities and found that the handling profile of 3-Bromo-1H-Pyrazolo[4,3-C]Pyridine reduced hassles. It doesn’t fume, degrade, or generate noxious byproducts under normal storage. Proper ventilation, gloves, and basic PPE suffice—no need for extreme low-temperature storage or constant atmosphere control. Compare that with sulfonated or fluorinated analogs, and the practical differences for daily lab life become obvious.
Waste streams also matter. 3-Bromo-1H-Pyrazolo[4,3-C]Pyridine doesn’t introduce difficult-to-dispose heavy metals or highly persistent organic residues, making it easier to manage compliance with green chemistry guidelines. Of course, nothing gets a free pass in modern labs; regular solvent recovery and adherence to standard waste disposal policies remain essential. But fewer headaches translating from bench to larger-scale preparation gives R&D teams a leg up.
A common struggle I saw in research groups is uneven access to high-quality intermediates. Some students or new staff order from unfamiliar vendors, risking impure or mismatched materials. That rarely happens with 3-Bromo-1H-Pyrazolo[4,3-C]Pyridine sourced from established suppliers. Transparent quality data, lot-to-lot consistency, and thorough paperwork set a standard for reliability. As a result, multiple teams, even in different parts of the world, can repeat experiments and trust their findings. This consistency matters—reproducibility is at the heart of credible science, and it can make or break grant renewals and collaborative projects.
Pricing also counts in a world where research budgets rarely stretch far enough. As more manufacturers produce this compound, costs come down, opening access to university labs and early-stage ventures. In one project I supported, rapid prototyping of kinase inhibitor libraries used bulk 3-Bromo-1H-Pyrazolo[4,3-C]Pyridine. The project's success relied on both quality and price; affordable access meant more candidates screened in less time—all at a justifiable cost.
Not every lab has seamless supply chains. Import regulations, demand spikes, and geopolitical tensions sometimes squeeze availability. In recent years, some researchers faced backlogs, tracing delays back to raw material shortages or customs bottlenecks. Standing partnerships with suppliers can help. In my experience, building a roster of approved vendors—not just defaulting to the cheapest—helps buffer against supply hiccups. Labs should invest in early planning, proactive order management, and maintain some extra stock of mission-critical intermediates.
Another growing solution comes through collaborative consortia. Some universities and institutes partner to jointly purchase and share batches of high-value chemicals, spreading costs and reducing risk of shortages. This collective approach delivers cost savings and improves access—especially important for regions with less mature chemical distribution networks.
Chemical education stands on the shoulders of practical experience. I’ve guided students through capstone projects and senior theses, and the frustration is real when a key intermediate fails to perform. 3-Bromo-1H-Pyrazolo[4,3-C]Pyridine consistently provides clear reaction outcomes, teaching new chemists what reliable reagents look like. Its robust nature enables students to focus on mastering technique, not troubleshooting poor reagents. This confidence, built up through repeated positive experiences, translates into bolder experimental design and deeper engagement with advanced chemistry.
Some programs now run entire rounds of medicinal chemistry training using pyrazolopyridine scaffolds. The real-world value here can’t be overstated. Training tomorrow’s scientists with compounds that see action in real drug discovery or agrochemical development bridges the gap between classroom theory and professional R&D.
Lab safety officers evaluate hundreds of chemicals each year for compliance. Compounds like 3-Bromo-1H-Pyrazolo[4,3-C]Pyridine ease the process. Their documentation is up to par, with hazard statements and risk assessments clear and accessible. Its predictable hazard profile—less acute than more heavily halogenated or energetically unstable analogs—speeds up safety clearance for new projects. Of course, every lab remains responsible for full local safety precautions, but compounds with less ambiguous risk profiles reduce administrative friction and make regulatory filings less burdensome.
This lower regulatory barrier translates to smoother project approval. Over time, less paperwork and simpler compliance help project managers allocate more effort to scientific work rather than bureaucratic oversight.
The chemical industry doesn’t thrive on tradition alone; it moves forward on innovation. Having reliable, flexible intermediates like 3-Bromo-1H-Pyrazolo[4,3-C]Pyridine fuels the process. From straightforward medicinal chemistry to materials science research, its adaptability allows teams to test new hypotheses and rapidly move from idea to data. I have seen biotech start-ups leverage this scaffold to generate diverse patent filings in record time, iterating faster than competitors stuck with less reactive or less available chemistries.
In my own consulting work, I’ve recommended moving projects up a notch by switching to brominated scaffolds when delays or low yields held teams back. Each successful switch reinforced the message: spend time on strategic planning, but also choose reagents that offer real world problem-solving.
The landscape of research chemicals is packed with options. But few compounds balance reactivity, reliability, and adaptability in the way 3-Bromo-1H-Pyrazolo[4,3-C]Pyridine does. Its role as a modular building block means researchers aren’t boxed in—they can adjust, diversify, and expand their syntheses with ease. Every team needs sturdy workhorses in their toolkit. Over years spent in crowded labs and tight timelines, compounds like this one keep showing up, making the road from concept to discovery just a little bit smoother.
Young scientists and seasoned professionals alike benefit from reliable tools. 3-Bromo-1H-Pyrazolo[4,3-C]Pyridine stands out for its practical value, cost-effectiveness, and widespread utility across chemistry-driven industries. Investing in core reagents that underwrite both straightforward and ambitious projects keeps research both productive and forward-thinking.
Looking ahead, accessibility and flexibility grow more important with each passing year. Scientific progress increasingly hinges on choices made in the supply room as much as in the design phase. Compounds like this one, tested and trusted, give scientists the confidence and freedom to chase the next breakthrough.